The Europe viscosupplementation market is witnessing a remarkable growth trajectory, with the industry projected to achieve a valuation of USD 12.03 billion by 2033. Starting from an estimated market size of USD 4.49 billion in 2022, this sector is anticipated to close 2023 with a value of USD 4.91 billion, representing a steady rise driven by increasing demand for innovative treatments in osteoarthritis and joint care.
Viscosupplementation, a minimally invasive procedure involving the injection of hyaluronic acid into joints, has gained prominence as a preferred treatment for alleviating pain and improving mobility in patients with osteoarthritis. The growing geriatric population, along with advancements in product formulations, has spurred this demand across Europe.
With an expected compound annual growth rate (CAGR) of 9.37% over the next decade, the Europe viscosupplementation market stands as a key area of growth in the region’s healthcare landscape. Experts attribute this upward trend to increased awareness of non-surgical treatment options and innovations in hyaluronic acid products.
Industry stakeholders are positioning themselves to capture this expanding market by developing enhanced viscosupplementation products that offer improved efficacy and longer-lasting relief. The growing trend of early diagnosis and preventive care for joint disorders is further fueling the market’s expansion.
Key Takeaways from the Market Study:
- The market for viscosupplementation in Europe expanded at a CAGR of 3.3% from 2018 to 2022.
- The United Kingdom viscosupplementation market is anticipated to grow at a CAGR of 9.8% over the course of the projected period.
- From 2023 to 2033, the France viscosupplementation market is anticipated to grow at a 9.1% CAGR.
- Germany’s share of the European viscosupplementation market is expected to grow by 8.2% between 2023 and 2033.
- During the anticipated period, the Spain viscosupplementation market is expected to grow at a 6.3% CAGR.
- The market for viscosupplementation in Italy is anticipated to grow at a CAGR of 5.7% over the projected period.
- A 7.9% CAGR is anticipated for the hospitals category over the course of the projection period.
- For single injection viscosupplementation, a CAGR of 8.2% is estimated for the anticipated time frame.
“Increasing joint injuries and awareness towards various kinds of wellness programs to boost the Europe viscosupplementation market growth,” remarks an FMI analyst.
Enhanced Interest in Market Trends: Access In-Depth Analysis and Insights with Our Full Report!
Competitive Landscape:
The use of cutting-edge technology by major manufacturers in the production of viscosupplementation is expected to raise the demand for cryotherapy technologies in Europe.
Key Developments:
- Anika Therapeutics, Inc. declared in 2022 that Health Canada has approved using CINGAL as a medical instrument for treating knee osteoarthritis (O.A.)-related pain.
- An exclusive global collaborative agreement to develop, produce, and sell IgM antibody agonists for three cancer targets and three immunology/inflammation targets was finalized in 2022, according to a press release from Sanofi S.A. and IGM Bioscience.
- With the debut of its revolutionary portfolio in Spain in 2022, Fidia Farmaceutici S.p.A. leveraged the restorative power of hyaluronic acid. At the 20th Aesthetic & Anti-aging Medicine World Congress 2022 (AMWC) in Monte Carlo, Fidia Farmaceutici S.p.A. showcased its Aesthetic Care portfolio together with a scientific symposium on its ground-breaking ACP (Auto-Crosslinked Polymer) technology.
Key companies profiled:
- Anika Therapeutics Inc.
- Sanofi S.A.
- Zimmer Biomet Holdings
- Meda AB
- Ferring B.V
- Fidia Pharmaceutici S.p.A
- Bioventus LLC
- Teva Pharmaceutical Industries Ltd.
- VIRCHOW BIOTECH
- Lifecore Biomedical
Segmentation Analysis of the Europe Viscosupplementation Market:
By Product:
- Single Injection
- Three Injection
- Five Injection
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Orthopedic Clinics
By Region:
- Western Europe
- Eastern Europe
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube